Skip to main content
Top
Published in: Infection 4/2012

01-08-2012 | Clinical and Epidemiological Study

Comparative study on infection-induced thrombocytopenia among returned travellers

Authors: K.-H. Herbinger, M. Schunk, H. D. Nothdurft, F. von Sonnenburg, T. Löscher, G. Bretzel

Published in: Infection | Issue 4/2012

Login to get access

Abstract

Background

Thrombocytopenia is a frequent finding among ill returned travellers and may be caused by a large number of different conditions, including infectious diseases specific or typical for tropical and subtropical regions. In order to assess the diagnostic significance of thrombocytopenia we investigated a large cohort of returned travellers.

Methods

This was a comparative study in which data collected on 19,473 returned travellers who consulted the outpatient travel clinic of the the University of Munich Hospital between 1999 and 2009 were analysed. Of these, 732 (3.8%) travellers were diagnosed with thrombocytopenia, and their data were compared with those of the remaining 18,741 travellers with normal platelet counts.

Results

Thrombocytopenia was significantly more frequent among patients with malaria (63%), acute human immunodeficiency virus infection (48%), dengue fever/dengue haemorrhagic fever (DF/DHF; 47%), Epstein–Barr virus infectious mononucleosis (23%), paratyphoid/typhoid fever (14%), and rickettsiosis (12%). Malaria and DF/DHF caused 25% of all cases of thrombocytopenia (platelet count <140,000/μl) and 75% of all cases of severe thrombocytopenia (platelet count <30,000/μl). Sex, age, country of origin, duration and type of travel were not significantly correlated with thrombocytopenia. The most frequent travel destinations were Asia (42%), Africa (33%), and Latin America (14%). Travellers to Sub-Saharan Africa (high risk for malaria) and to South/South-east Asia (high risk for DF/DHF) had the highest relative risk for thrombocytopenia.

Conclusion

Platelet count among returned travellers is an essential screening parameter, as thrombocytopenia is highly correlated with important infectious diseases, particularly with malaria and DF/DHF.
Literature
1.
go back to reference Fleming AF, de Silva PS. Haematological diseases in the tropics. In: Manson’s tropical diseases. Elsevier WB Saunders, 2003;174. Fleming AF, de Silva PS. Haematological diseases in the tropics. In: Manson’s tropical diseases. Elsevier WB Saunders, 2003;174.
2.
go back to reference George JN. Platelets. Lancet. 2000;355:1531–9. George JN. Platelets. Lancet. 2000;355:1531–9.
3.
go back to reference Dolan TT. Thrombocytopenia in experimental babesiosis. Trans R Soc Trop Med Hyg. 1974;68:274. Dolan TT. Thrombocytopenia in experimental babesiosis. Trans R Soc Trop Med Hyg. 1974;68:274.
4.
go back to reference Kettner F, Reyers F, Miller D. Thrombocytopenia in canine babesiosis and its clinical usefulness. J S Afr Vet Assoc. 2003;74:63–8.PubMed Kettner F, Reyers F, Miller D. Thrombocytopenia in canine babesiosis and its clinical usefulness. J S Afr Vet Assoc. 2003;74:63–8.PubMed
5.
go back to reference Costa CH, Werneck GL, Costa DL, Holanda TA, Aguiar GB, Carvalho AS, Cavalcanti JC, Santos LS. Is severe visceral leishmaniasis a systemic inflammatory response syndrome? A case control study. Rev Soc Bras Med Trop. 2010;43:386–92.PubMedCrossRef Costa CH, Werneck GL, Costa DL, Holanda TA, Aguiar GB, Carvalho AS, Cavalcanti JC, Santos LS. Is severe visceral leishmaniasis a systemic inflammatory response syndrome? A case control study. Rev Soc Bras Med Trop. 2010;43:386–92.PubMedCrossRef
6.
go back to reference Gürkan E, Başlamişli F, Güvenç B, Bozkurt B, Unsal C. Immune thrombocytopenic purpura associated with Brucella and Toxoplasma infections. Am J Hematol. 2003;74:52–4.PubMedCrossRef Gürkan E, Başlamişli F, Güvenç B, Bozkurt B, Unsal C. Immune thrombocytopenic purpura associated with Brucella and Toxoplasma infections. Am J Hematol. 2003;74:52–4.PubMedCrossRef
7.
go back to reference Tuon F, Higashino HR, Amato VS, Nicodemo AC. Acute immune-mediated thrombocytopenic purpura related to Toxoplasma gondii infection. Int J Infect Dis. 2008;12:671–2.PubMedCrossRef Tuon F, Higashino HR, Amato VS, Nicodemo AC. Acute immune-mediated thrombocytopenic purpura related to Toxoplasma gondii infection. Int J Infect Dis. 2008;12:671–2.PubMedCrossRef
8.
go back to reference Robins-Browne RM, Schneider J, Metz J. Thrombocytopenia in trypanosomiasis. Am J Trop Med Hyg. 1975;24:226–31.PubMed Robins-Browne RM, Schneider J, Metz J. Thrombocytopenia in trypanosomiasis. Am J Trop Med Hyg. 1975;24:226–31.PubMed
9.
go back to reference Davis CE. Thrombocytopenia: a uniform complication of African trypanosomiasis. Acta Trop. 1982;39:123–33.PubMed Davis CE. Thrombocytopenia: a uniform complication of African trypanosomiasis. Acta Trop. 1982;39:123–33.PubMed
10.
go back to reference Tribulatti MV, Mucci J, Van Rooijen N, Leguizamón MS, Campetella O. The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas’ disease by reducing the platelet sialic acid contents. Infect Immun. 2005;73:201–7.PubMedCrossRef Tribulatti MV, Mucci J, Van Rooijen N, Leguizamón MS, Campetella O. The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas’ disease by reducing the platelet sialic acid contents. Infect Immun. 2005;73:201–7.PubMedCrossRef
11.
go back to reference Jadhav UM, Patkar VS, Kadam NN. Thrombocytopenia in malaria—correlation with type and severity of malaria. J Assoc Physicians India. 2004;52:615–8.PubMed Jadhav UM, Patkar VS, Kadam NN. Thrombocytopenia in malaria—correlation with type and severity of malaria. J Assoc Physicians India. 2004;52:615–8.PubMed
12.
go back to reference Shaik QH, Ahmad SM, Abbasi A, Malik SA, Sahito AA, Muni SM. Thrombocytpenia in malaria. J Coll Physicians Surg Pak. 2009;19:708–10. Shaik QH, Ahmad SM, Abbasi A, Malik SA, Sahito AA, Muni SM. Thrombocytpenia in malaria. J Coll Physicians Surg Pak. 2009;19:708–10.
13.
go back to reference Schexneider KI, Reedy EA. Thrombocytopenia in dengue fever. Curr Hematol Rep. 2005;4:145–8.PubMed Schexneider KI, Reedy EA. Thrombocytopenia in dengue fever. Curr Hematol Rep. 2005;4:145–8.PubMed
14.
go back to reference Bandyopadhyay S, Lum LC, Kroeger A. Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever. Trop Med Int Health. 2006;11:1238–55.PubMedCrossRef Bandyopadhyay S, Lum LC, Kroeger A. Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever. Trop Med Int Health. 2006;11:1238–55.PubMedCrossRef
16.
go back to reference Sundell IB, Koka PS. Thrombocytopenia in HIV infection: impairment of platelet formation and loss correlates with increased c-Mpl and ligand thrombopoietin expression. Curr HIV Res. 2006;4:107–16.PubMedCrossRef Sundell IB, Koka PS. Thrombocytopenia in HIV infection: impairment of platelet formation and loss correlates with increased c-Mpl and ligand thrombopoietin expression. Curr HIV Res. 2006;4:107–16.PubMedCrossRef
17.
go back to reference Marks KM, Clarke RM, Bussel JB, Talal AH, Glesby MJ. Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy. J Acquir Immune Defic Syndr. 2009;52:595–9.PubMedCrossRef Marks KM, Clarke RM, Bussel JB, Talal AH, Glesby MJ. Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy. J Acquir Immune Defic Syndr. 2009;52:595–9.PubMedCrossRef
18.
go back to reference Steeper TA, Horwitz CA, Moore SB, Henle W, Henle G, Ellis R, Flynn PJ. Severe thrombocytopenia in Epstein–Barr virus-induced mononucleosis. West J Med. 1989;150:170–3.PubMed Steeper TA, Horwitz CA, Moore SB, Henle W, Henle G, Ellis R, Flynn PJ. Severe thrombocytopenia in Epstein–Barr virus-induced mononucleosis. West J Med. 1989;150:170–3.PubMed
19.
go back to reference Likic R, Kuzmanic D. Severe thrombocytopenia as a complication of acute Epstein–Barr virus infection. Wien Klin Wochenschr. 2004;116:47–50.PubMedCrossRef Likic R, Kuzmanic D. Severe thrombocytopenia as a complication of acute Epstein–Barr virus infection. Wien Klin Wochenschr. 2004;116:47–50.PubMedCrossRef
20.
go back to reference Rasche FM, Uhel B, Krüger DH, Karges W, Czock D, Hampl W, Keller F, Meisel H, von Müller L. Thrombocytopenia and acute renal failure in Puumala hantavirus infections. Emerg Infect Dis. 2004;10:1420–5.PubMedCrossRef Rasche FM, Uhel B, Krüger DH, Karges W, Czock D, Hampl W, Keller F, Meisel H, von Müller L. Thrombocytopenia and acute renal failure in Puumala hantavirus infections. Emerg Infect Dis. 2004;10:1420–5.PubMedCrossRef
21.
go back to reference Denecke B, Bigalke B, Haap M, Overkamp D, Lehnert H, Haas CS. Hantavirus infection: a neglected diagnosis in thrombocytopenia and fever? Mayo Clin Proc. 2010;85:1016–20.PubMedCrossRef Denecke B, Bigalke B, Haap M, Overkamp D, Lehnert H, Haas CS. Hantavirus infection: a neglected diagnosis in thrombocytopenia and fever? Mayo Clin Proc. 2010;85:1016–20.PubMedCrossRef
22.
go back to reference Fisgin T, Yarali N, Duru F, Kara A. CMV-induced immune thrombocytopenia and excessive hematogones mimicking an acute B-precursor lymphoblastic leukemia. Leuk Res. 2003;27:193–6.PubMedCrossRef Fisgin T, Yarali N, Duru F, Kara A. CMV-induced immune thrombocytopenia and excessive hematogones mimicking an acute B-precursor lymphoblastic leukemia. Leuk Res. 2003;27:193–6.PubMedCrossRef
24.
go back to reference Pancholi P, Kolbert CP, Mitchell PD, Reed KD Jr, Dumler JS, Bakken JS, Telford SR 3rd, Persing DH. Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J Infect Dis. 1995;172:1007–12.PubMedCrossRef Pancholi P, Kolbert CP, Mitchell PD, Reed KD Jr, Dumler JS, Bakken JS, Telford SR 3rd, Persing DH. Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J Infect Dis. 1995;172:1007–12.PubMedCrossRef
25.
go back to reference Mert A, Ozaras R, Tabak F, Bilir M, Ozturk R. Mediterranean spotted fever: a review of fifteen cases. J Dermatol. 2006;33:103–7.PubMedCrossRef Mert A, Ozaras R, Tabak F, Bilir M, Ozturk R. Mediterranean spotted fever: a review of fifteen cases. J Dermatol. 2006;33:103–7.PubMedCrossRef
26.
go back to reference Chapman AS, Bakken JS, Folk SM, Paddock CD, Bloch KC, Krusell A, Sexton DJ, Buckingham SC, Marshall GS, Storch GA, Dasch GA, McQuiston JH, Swerdlow DL, Dumler SJ, Nicholson WL, Walker DH, Eremeeva ME, Tickborne Rickettsial Diseases Working Group; CDC. Diagnosis and management of tickborne rickettsial diseases: rocky mountain spotted fever, ehrlichioses, and anaplasmosis—United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep. 2006;55:1–27. Chapman AS, Bakken JS, Folk SM, Paddock CD, Bloch KC, Krusell A, Sexton DJ, Buckingham SC, Marshall GS, Storch GA, Dasch GA, McQuiston JH, Swerdlow DL, Dumler SJ, Nicholson WL, Walker DH, Eremeeva ME, Tickborne Rickettsial Diseases Working Group; CDC. Diagnosis and management of tickborne rickettsial diseases: rocky mountain spotted fever, ehrlichioses, and anaplasmosis—United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep. 2006;55:1–27.
27.
go back to reference Faierman D, Ross FA, Seckler SG. Typhoid fever complicated by hepatitis, nephritis, and thrombocytopenia. JAMA. 1972;221:60–1.PubMedCrossRef Faierman D, Ross FA, Seckler SG. Typhoid fever complicated by hepatitis, nephritis, and thrombocytopenia. JAMA. 1972;221:60–1.PubMedCrossRef
28.
go back to reference Hustinx WN, Nio Y, Speelman P. Abdominal typhus and paratyphoid fever in 2 academic hospitals: 1984–1990. (in Dutch) Ned Tijdschr Geneeskd. 1993;137:291–4.PubMed Hustinx WN, Nio Y, Speelman P. Abdominal typhus and paratyphoid fever in 2 academic hospitals: 1984–1990. (in Dutch) Ned Tijdschr Geneeskd. 1993;137:291–4.PubMed
29.
go back to reference Alugupulli KR, Michelson AD, Joris I, Schwan TG, Hodivala-Dilke K, Hynes RO, Leong JM. Spirochete–platelet attachment and thrombocytopenia in murine relapsing fever borreliosis. Blood. 2003;102:2843–50.CrossRef Alugupulli KR, Michelson AD, Joris I, Schwan TG, Hodivala-Dilke K, Hynes RO, Leong JM. Spirochete–platelet attachment and thrombocytopenia in murine relapsing fever borreliosis. Blood. 2003;102:2843–50.CrossRef
30.
go back to reference Nicodemo AC, Negro del G, Amato Neto V. Thrombocytopenia and leptospirosis. Rev Inst Med Trop São Paulo. 1990;32:252–9.PubMed Nicodemo AC, Negro del G, Amato Neto V. Thrombocytopenia and leptospirosis. Rev Inst Med Trop São Paulo. 1990;32:252–9.PubMed
31.
go back to reference Wagenaar JF, Goris MC, Partiningrum DL, Isbandrio B, Hartskeerl RA, Brandjes DP, Meijers JC, Gasern MH, van Gorp EC. Coagulation disorders in patients with severe leptospirosis are associated with severe bleeding and mortality. Trop Med Int Health. 2010;15:152–9.PubMedCrossRef Wagenaar JF, Goris MC, Partiningrum DL, Isbandrio B, Hartskeerl RA, Brandjes DP, Meijers JC, Gasern MH, van Gorp EC. Coagulation disorders in patients with severe leptospirosis are associated with severe bleeding and mortality. Trop Med Int Health. 2010;15:152–9.PubMedCrossRef
32.
go back to reference Juhlin L. Early congenital syphilis and thrombocytopenia. Acta Derm Venereol. 1968;48:166–9.PubMed Juhlin L. Early congenital syphilis and thrombocytopenia. Acta Derm Venereol. 1968;48:166–9.PubMed
33.
go back to reference Di Mario A, Sica S, Zini G, Salutari P, Leone G. Microangiopathic hemolytic anemia and severe thrombocytopenia in Brucella infection. Ann Hematol. 1995;70:59–60.PubMedCrossRef Di Mario A, Sica S, Zini G, Salutari P, Leone G. Microangiopathic hemolytic anemia and severe thrombocytopenia in Brucella infection. Ann Hematol. 1995;70:59–60.PubMedCrossRef
34.
go back to reference Altuntas F, Eser B, Sari I, Yildiz O, Cetin M, Unal A. Severe thrombotic microangiopathy associated with brucellosis: successful treatment with plasmapheresis. Clin Appl Thromb Hemost. 2005;11:105–8.PubMedCrossRef Altuntas F, Eser B, Sari I, Yildiz O, Cetin M, Unal A. Severe thrombotic microangiopathy associated with brucellosis: successful treatment with plasmapheresis. Clin Appl Thromb Hemost. 2005;11:105–8.PubMedCrossRef
35.
go back to reference Guo YL, Liu DQ, Bian Z, Zhang CY, Zen K. Down-regulation of platelet surface CD47 expression in Escherichia coli O157:H7 infection-induced thrombocytopenia. PLoS One. 2009;4:e7131.PubMedCrossRef Guo YL, Liu DQ, Bian Z, Zhang CY, Zen K. Down-regulation of platelet surface CD47 expression in Escherichia coli O157:H7 infection-induced thrombocytopenia. PLoS One. 2009;4:e7131.PubMedCrossRef
Metadata
Title
Comparative study on infection-induced thrombocytopenia among returned travellers
Authors
K.-H. Herbinger
M. Schunk
H. D. Nothdurft
F. von Sonnenburg
T. Löscher
G. Bretzel
Publication date
01-08-2012
Publisher
Springer-Verlag
Published in
Infection / Issue 4/2012
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-012-0242-9

Other articles of this Issue 4/2012

Infection 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.